Cargando…

Efficacy and safety of once daily dosing of colistin to critically ill patients

Detalles Bibliográficos
Autores principales:	Skiada, A, Pavleas, J, Topalis, T, Georgiou, K, Siggouna, D, Thomopoulos, G, Daikos, GL, Floros, G
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2934037/ http://dx.doi.org/10.1186/cc8288

Ejemplares similares

Efficacy and safety of colistin in the treatment of infections in the ICU caused by multidrug-resistant Gram-negative organisms
por: Pavleas, J, et al.
Publicado: (2006)

Once Versus Thrice Daily Colistin in Critically Ill Ptients with Multi-Drug Resistant Infections
por: Ghazaeian, Monireh, et al.
Publicado: (2017)

Trends of resistance of Gram-negative bacteria in the ICU during a 3-year period
por: Skiada, A, et al.
Publicado: (2008)

Inhaled colistin for the treatment of ventilator-associated tracheobronchitis in critically ill patients
por: Athanassa, Z, et al.
Publicado: (2011)

Pharmacokinetics of inhaled colistin in critically ill patients with ventilator-associated tracheobronchitis
por: Athanassa, Z, et al.
Publicado: (2012)

The use of recombinant factor VIIa as a haemostatic agent in ICU patients
por: Vernikos, P, et al.
Publicado: (2004)

Once-daily dosing of gentamicin.
por: Soper, D E
Publicado: (1998)

Intravenous fosfomycin therapy in critically ill patients infected with colistin-resistant enterobacteriacae
por: Mukherjee, DN, et al.
Publicado: (2015)

Emergence of isolates that are intrinsically resistant to colistin in critically ill patients: are we selecting them out?
por: Sivakumar, MN, et al.
Publicado: (2015)

Daily interruption of central venous catheters in critically ill ICU patients
por: Myrianthefs, P, et al.
Publicado: (2004)

Efficacy and safety of an NRTI-sparing regimen in antiretroviral-naïve HIV-infected patients: once-daily maraviroc plus lopinavir/ritonavir
por: Nozza, S, et al.
Publicado: (2010)

Recombinant human erythropoietin therapy in critically ill patients
por: Georgopoulos, D, et al.
Publicado: (2005)

Rare fungal infectious agents: a lurking enemy
por: Skiada, Anna, et al.
Publicado: (2017)

Epidemiology and Diagnosis of Mucormycosis: An Update
por: Skiada, Anna, et al.
Publicado: (2020)

Convulsions in a critically ill patient on hemodialysis: Possible role of low dose colistin
por: Sodhi, Kanwalpreet, et al.
Publicado: (2014)

Colistin dosing for treatment of multidrug-resistant Pseudomonas in critically ill patients - please, be adequate!
por: Honoré, Patrick M, et al.
Publicado: (2014)

The use of once-daily dosing of gentamicin in obstetrics and gynecology.
por: Wiesenfeld, H C, et al.
Publicado: (1998)

Systemic rheumatic diseases in the ICU
por: Vernikos, P, et al.
Publicado: (2009)

O05 - Once-daily tiotropium in adolescents with symptomatic asthma despite inhaled corticosteroid treatment: a dose-ranging study
por: Vogelberg, Christian, et al.
Publicado: (2014)

Potential benefit of dolutegravir once daily: efficacy and safety
por: Fantauzzi, Alessandra, et al.
Publicado: (2013)

The 10 year safety and efficacy of tenofovir disoproxil fumarate (TDF)-containing once-daily highly active antiretroviral therapy (HAART)
por: Cassetti, I, et al.
Publicado: (2010)

5-year safety and efficacy of the once-daily antiretroviral regimen of efavirenz (EFV)/emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF)
por: Lazzarin, A, et al.
Publicado: (2010)

Implementing intensive insulin therapy in daily practice reduces the incidence of critical illness polyneuropathy and/or myopathy
por: Berends, N, et al.
Publicado: (2008)

The use of a darunavir/ritonavir once-daily regimen in two pregnant women
por: Lambert, JS, et al.
Publicado: (2010)

Long-Term Effectiveness, Safety, and Tolerability of Twice-Daily Dosing with Deferasirox in Children with Transfusion-Dependent Thalassemias Unresponsive to Standard Once-Daily Dosing
por: Buaboonnam, Jassada, et al.
Publicado: (2021)

485 Colistin Nephrotoxicity in Critically Ill Patients after Implementation of a New Dosing Strategy
por: Özel, Ayşe Serra, et al.
Publicado: (2014)

A Randomized Clinical Trial Evaluating the Efficacy of Colistin Loading Dose in Critically Ill Children
por: Fatehi, Shiva, et al.
Publicado: (2019)

Twice-daily versus once-daily lisinopril and losartan for hypertension: Real-world effectiveness and safety
por: Derington, Catherine G., et al.
Publicado: (2020)

The pharmacokinetics of once-daily dosing with gentamicin in women with postpartum endometritis.
por: Sunyecz, J A, et al.
Publicado: (1998)

Chronopharmacokinetics of once daily dosed aminoglycosides in hospitalized infectious patients
por: van Maarseveen, Erik, et al.
Publicado: (2015)

Pharmacokinetic (PK) and pharmacodynamic analyses of once- and twice-daily darunavir/ritonavir (DRV/r) in the ODIN trial
por: Sekar, V, et al.
Publicado: (2010)

Population Pharmacokinetics of Colistin Methanesulfonate Sodium and Colistin in Critically Ill Patients: A Systematic Review
por: Zabidi, Mohd Shafie, et al.
Publicado: (2021)

Pharmacokinetics of antituberculosis drugs in critically ill patients with tuberculosis and acute respiratory failure
por: Hernandez-Cardenas, CH, et al.
Publicado: (2014)

Intrathecal administration of colistin, vancomycin and amikacin for central nervous system infections in ICU neurosurgical patients
por: Alexandropoulos, P, et al.
Publicado: (2015)

Use of once-daily raltegravir-based HAART in HIV-infected injection drug users
por: Tossonian, HK, et al.
Publicado: (2010)

Population pharmacokinetic modelling of once-daily ritonavir-boosted darunavir in HIV-infected patients
por: Dickinson, L, et al.
Publicado: (2010)

The Effect of Different Colistin Dosing Regimens on Nephrotoxicity: A Cohort Study
por: Samarkos, Michael, et al.
Publicado: (2022)

Once-daily dolutegravir is superior to once-daily darunavir/ritonavir in treatment-naïve HIV-1-positive individuals: 96 week results from FLAMINGO
por: Molina, Jean-Michel, et al.
Publicado: (2014)

High-Dose, Extended-Interval Colistin Administration in Critically Ill Patients: Is This the Right Dosing Strategy? A Preliminary Study
por: Dalfino, Lidia, et al.
Publicado: (2012)

Colistin Dosing Regimens against Pseudomonas aeruginosa in Critically Ill Patients: An Application of Monte Carlo Simulation
por: Nguyen, Van Thi Khanh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t7chqu9kbdv0koabicbbk6l9ht